{"originalText": "，缘于入院前2个月在我院诊为“降结肠癌”，并于2014.04.28在全麻上行“腹腔镜辅助上根治性右半结肠切除术+小肠肿物切除术”，术顺，术后病理（201412664），：（右半结肠），：1.肠隆起型绒毛状-管状腺癌II级，癌组织侵犯脉管组织，侵及浅肌层。手术标本双切端及另送（下切端）、（上切端）均未见癌浸润；找到肠周淋巴结23个，均未见癌转移。肠周见癌结节1个。2.肠绒毛状-管状腺瘤，伴腺下皮低级别下皮内瘤变。（小肠），：送检组织镜上为梭形细胞增生结节（最大径0.5CM），细胞核呈短梭形，可见核仁，胞浆嗜碱性，排列呈束状，核分裂像少见（&LT;2个/50HPF），结合免疫组化结果，考虑危险度低的胃肠道间质瘤，因送检组织均为肿瘤组织，未见肠粘膜，无法判断切缘情况，请结合临床诊断。建议随访。，免疫组化结果：CK(PAN)（-），CD117（+++），CD34（++），DOG1（+++），DESMIN（-），H-CALDESMON（-），ACTIN(SM)（-），S100（个别细胞阳性），NF(PAN)（-），CD57（-），KI67（2%阳性）。术后予营养支持治疗，恢复良好。术后按“奥沙利铂(齐沙)150MGIVGTTD1+希罗达1000.00MGPOBIDD2-15”方案化疗，于2014-05-28行第1周期化疗。今入院行术后第2周期化疗，门诊拟“降结肠癌术后化疗”收住入院。自术后出院以来，精神、睡眠、食欲尚可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 19}, {"label_type": "手术", "overlap": 0, "start_pos": 39, "end_pos": 63}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 110}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 184, "end_pos": 193}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 301, "end_pos": 307}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 323}, {"end_pos": 501, "label_type": "药物", "overlap": 0, "start_pos": 497}, {"end_pos": 504, "label_type": "药物", "overlap": 0, "start_pos": 502}, {"end_pos": 521, "label_type": "药物", "overlap": 0, "start_pos": 518}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 582, "end_pos": 588}]}
